Skip to main content
padlock icon - secure page this page is secure

The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study

Buy Article:

$106.67 + tax (Refund Policy)

In this study, we first investigated the change of the morphology of paclitaxel (PTX) nanocrystals by varying the type of stabilizer and increasing the amount of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in PTX/TPGS nanocrystals. Rod-shaped nanocrystals changed into relatively thermally stable spherical micelles as the amount of TPGS increased to 1/20 (PTX/TPGS). With these increasing amounts of TPGS, higher cytotoxicity and cellular uptake were observed in P-glycoprotein-overexpressing PTX-resistant (H460/TaxR) cancer cells. Compared to Taxol, PTX/Pluronic F127 (F127) (1/5) nanocrystals, PTX/TPGS (1/5) nanocrystals and PTX/TPGS (1/40) micelles showed significantly sustained in vitro release profiles. Pharmacokinetic studies showed that PTX from these nanoformulations was cleared more rapidly than PTX from Taxol after intravenous administration. However, although presenting an unfavorable pharmacokinetic profile, the biodistribution study showed that PTX/TPGS (1/40) micelles were more effective in promoting accumulation of PTX in drug resistant tumors than Taxol, due to the P-gp inhibition effect of TPGS.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: BIODISTRIBUTION; MULTIDRUG RESISTANCE; NANOCRYSTALS; PACLITAXEL; PHARMACOKINETICS

Document Type: Research Article

Publication date: January 1, 2016

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more